Recombinant protein · Agonist of growth hormone receptor (GHR) · developed by BioMarin Pharmaceutical
Human Growth Hormone (somatotropin) is a commercial product containing somatotropin, a recombinant growth hormone.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT06382155 | Phase 2 | Idiopathic Short Stature | Recruiting | BMRN |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Idiopathic Short Stature
Updated Nov 8, 2026. Something wrong or missing? Report it on the BMRN page.
See BMRN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
BMRN catalysts and pipeline →